Our Pricing

What Is the Mounjaro Price in September 2025?

Published: 10 September 2026

The mounjaro price september at Cured Pharmacy starts from £124.99 for genuine UK-licensed tirzepatide injections, with £20 off your first order using code Weightlossnew. As a UK-registered online pharmacy (GPhC 9012511), we provide transparent upfront pricing and free clinical consultations with our prescribing team, ensuring you receive safe, effective weight loss treatment without hidden costs.

Understanding the Mounjaro Price September 2025

When evaluating the mounjaro price september, it's essential to understand what you're paying for beyond the medication itself. Mounjaro (tirzepatide) is a prescription-only medicine licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. At Cured Pharmacy, our pricing includes the medication, a full clinical assessment by a UK-registered prescriber, discreet home delivery, and ongoing support from our pharmacist-led team.

The cost structure for tirzepatide injections reflects the medication's dual-action mechanism, targeting both GIP and GLP-1 receptors to regulate appetite and glucose metabolism [2]. In the SURMOUNT-1 trial, participants achieved an average weight reduction of 20.9% over 72 weeks with the 15mg maintenance dose, demonstrating why this treatment represents significant value despite the initial investment [3]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every patient receives personalised dosing guidance to optimise both safety and cost-effectiveness throughout their weight loss journey.

How the Mounjaro Price September Compares Across UK Pharmacies

The mounjaro price september varies across UK providers, but transparency remains crucial when comparing options. At Cured Pharmacy, we display our £124.99 starting price before you begin your consultation, eliminating surprise costs that some services add after assessment. This upfront approach reflects our commitment to honest healthcare pricing, with no membership fees or hidden subscription charges.

Many patients ask why tirzepatide pricing differs between pharmacies when the medication is identical. The answer lies in service models: some providers include additional lifestyle coaching programmes or extended prescriber consultations, while others focus on streamlined digital services. Our model balances accessibility with clinical rigour, offering free consultations under three minutes whilst maintaining full compliance with GPhC standards. The £20 discount with code Weightlossnew further reduces your first treatment cost, making September an ideal time to begin your weight management programme.

Factors Affecting September Pricing

Several factors influence the mounjaro price september beyond the medication cost itself. Supply chain dynamics, including manufacturer pricing and distribution logistics, can shift monthly. September often sees stable pricing as pharmacy stock levels normalise after summer demand fluctuations. Additionally, your prescribed dose determines the total treatment cost: starting doses of 2.5mg require less medication per pen than maintenance doses of 10mg or 15mg, creating natural price variations across your treatment timeline [4].

What Affects the Mounjaro Price September at Cured Pharmacy

The mounjaro price september at Cured Pharmacy reflects our commitment to sustainable, competitive pricing without compromising clinical standards. Our £124.99 starting price covers your initial 2.5mg dose, which you'll use for the first four weeks as your body adapts to tirzepatide's effects. This gradual dose escalation protocol, recommended by the manufacturer and NICE guidelines, minimises gastrointestinal side effects whilst allowing your prescriber to monitor your response [5].

As you progress through dose escalations—from 2.5mg to 5mg, then potentially to 7.5mg, 10mg, 12.5mg, or 15mg—your per-treatment cost adjusts to reflect the increased medication volume. However, higher doses correlate with greater weight loss outcomes in clinical trials, meaning the investment often yields proportionally better results. Our transparent pricing structure ensures you understand the full cost pathway before committing to treatment, with no obligation to continue if circumstances change.

Mounjaro Price September: Dosing Schedule and Cost Planning

Understanding how the mounjaro price september fits into your long-term budget requires clarity on the dosing schedule. Tirzepatide follows a structured escalation protocol: you begin with 2.5mg weekly for four weeks, then increase to 5mg for another four weeks, with further increases every four weeks until reaching your optimal maintenance dose [6]. Each pen contains four weekly doses, meaning one pen lasts one month regardless of your dose strength.

Most patients achieve their best results on maintenance doses between 10mg and 15mg, which they continue for as long as clinically appropriate and effective. In the SURMOUNT trials, participants maintained treatment for 72 weeks with sustained weight loss and improved metabolic markers [3]. When planning your budget, consider that weight management is a long-term commitment: the average treatment duration ranges from 12 to 24 months, though some patients require ongoing therapy to maintain their weight loss. Our team provides cost projections during your consultation to ensure the treatment aligns with your financial circumstances.

Monthly Cost Breakdown

The mounjaro price september translates to a monthly cost starting from £124.99 for your initial dose. As you escalate to higher doses, the monthly investment increases proportionally, but so does the clinical benefit. Our transparent pricing model means you'll always know your next month's cost before ordering, with no automatic renewals or surprise charges. The £20 discount on your first order reduces your initial financial commitment, allowing you to trial the treatment with reduced risk.

Comparing Mounjaro Price September with Alternative Treatments

When evaluating the mounjaro price september, patients often compare tirzepatide with other GLP-1 receptor agonists like semaglutide (Wegovy) or liraglutide (Saxenda). Wegovy starts from £124.99 at Cured Pharmacy, making it a lower-cost entry point, though clinical trials show tirzepatide produces greater average weight loss—20.9% versus 14.9% for semaglutide 2.4mg over similar timeframes [3][7]. This means the higher mounjaro price september may deliver better cost-per-kilogram-lost value for some patients.

Saxenda, priced from £124.99, requires daily injections rather than weekly administration, which some patients find less convenient despite the lower per-pen cost. Oral treatments like Wegovy tablets (from £124.99) offer an injection-free alternative, though with slightly different efficacy profiles. Your prescriber will discuss these options during your consultation, considering your weight loss goals, injection preferences, budget constraints, and medical history. There's no universally 'best' choice—the optimal treatment balances clinical effectiveness, tolerability, convenience, and affordability for your individual circumstances.

How to Access the Mounjaro Price September at Cured Pharmacy

Accessing the mounjaro price september at Cured Pharmacy begins with our free online consultation, which takes under three minutes to complete. You'll answer questions about your weight history, current BMI, previous weight loss attempts, existing medical conditions, and current medications. This information allows our UK-registered prescribers to assess whether Mounjaro is clinically appropriate and safe for you, as all prescription medicines require individual medical evaluation [8].

If approved, you'll receive your prescription electronically, and we'll dispense your medication from our GPhC-registered pharmacy premises. Delivery is discreet and typically arrives within 2-3 working days via tracked courier. Your first order qualifies for £20 off using code Weightlossnew, reducing your initial cost. We provide full patient information leaflets, injection technique guidance, and access to our pharmacist team for any questions during your treatment. Follow-up consultations ensure your dose remains optimal as you progress through your weight loss journey, with adjustments made based on your results and any side effects experienced.

Eligibility and Prescription Requirements

The mounjaro price september applies only to patients who meet clinical eligibility criteria. You must have a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Our prescribers cannot issue tirzepatide for cosmetic weight loss in patients below these thresholds, as this would fall outside MHRA-licensed indications and professional prescribing standards. During your consultation, you'll need to provide accurate weight and height measurements to calculate your BMI, ensuring safe and appropriate prescribing.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 10 September 2026]
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 10 September 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for managing overweight and obesity: Technology appraisal guidance. NICE. [accessed 10 September 2026]
5. Eli Lilly and Company. (2023). Mounjaro (tirzepatide) injection: Prescribing information. Lilly USA. [accessed 10 September 2026]
6. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on obesity and metabolic health: SURMOUNT-1 extension study. The Lancet, 401(10390), 1747-1757. [accessed 10 September 2026]
7. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 10 September 2026]
8. General Pharmaceutical Council. (2022). Standards for registered pharmacies. GPhC. [accessed 10 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.